Top Markets
Coin of the day
Noile-Immune Biotech Inc. Noile-Immune Biotech Inc.

Noile-Immune Biotech Inc.

4893
Rank in Stocks #26562
Established in 2015 and based in Minato, Japan, this company is dedicated to... Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
Share Price
$0.91341182
Market Cap
$39.55M
Change (1 day)
-0.71%
Change (1 year)
-26.05%
Country
JP
Trade Noile-Immune Biotech Inc. (4893)

Category

P/E ratio for Noile-Immune Biotech Inc. (4893)
P/E ratio as of 2026 TTM: 0
According to Noile-Immune Biotech Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Noile-Immune Biotech Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
29.20 -
US
30.62 -
NL
32.46 -
AU
- -
CH
-7.93 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.